PL1676591T3 - Kompozycje i sposoby tworzenia unaczynionego środowiska dla przeszczepu komórkowego - Google Patents

Kompozycje i sposoby tworzenia unaczynionego środowiska dla przeszczepu komórkowego

Info

Publication number
PL1676591T3
PL1676591T3 PL05257209T PL05257209T PL1676591T3 PL 1676591 T3 PL1676591 T3 PL 1676591T3 PL 05257209 T PL05257209 T PL 05257209T PL 05257209 T PL05257209 T PL 05257209T PL 1676591 T3 PL1676591 T3 PL 1676591T3
Authority
PL
Poland
Prior art keywords
compositions
create
methods
cellular transplantation
vascularized environment
Prior art date
Application number
PL05257209T
Other languages
English (en)
Inventor
Alireza Rezania
Jean Xu
Ragae Ghabrial
Original Assignee
Lifescan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan, Inc. filed Critical Lifescan, Inc.
Publication of PL1676591T3 publication Critical patent/PL1676591T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL05257209T 2004-11-24 2005-11-23 Kompozycje i sposoby tworzenia unaczynionego środowiska dla przeszczepu komórkowego PL1676591T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63063304P 2004-11-24 2004-11-24
EP05257209.6A EP1676591B1 (en) 2004-11-24 2005-11-23 Compositions and methods to create a vascularized environment for cellular transplantation

Publications (1)

Publication Number Publication Date
PL1676591T3 true PL1676591T3 (pl) 2018-12-31

Family

ID=36335127

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05257209T PL1676591T3 (pl) 2004-11-24 2005-11-23 Kompozycje i sposoby tworzenia unaczynionego środowiska dla przeszczepu komórkowego

Country Status (3)

Country Link
EP (1) EP1676591B1 (pl)
ES (1) ES2686777T3 (pl)
PL (1) PL1676591T3 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016046715A1 (en) * 2014-09-25 2016-03-31 Università Degli Studi Di Trento Method for manufacturing porous scaffolds for biomedical uses and scaffolds thereof
CN108245709A (zh) * 2017-12-13 2018-07-06 上海昊海生物科技股份有限公司 一种预防包膜挛缩的仿生型几丁糖填充剂及其制备方法
EP3897452A4 (en) * 2018-12-21 2022-09-07 Tepha, Inc. ABSORBABLE NON-WOVEN POUCHES FOR MEDICAL DEVICE IMPLANTS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030368A1 (en) * 1999-10-25 2001-05-03 Beth Israel Deaconess Medical Center Method for pr-39 peptide regulated stimulation of angiogenesis
US6660737B2 (en) * 2001-05-04 2003-12-09 The Procter & Gamble Company Medicinal uses of hydrazones
GB0113697D0 (en) * 2001-06-06 2001-07-25 Smith & Nephew Fixation devices for tissue repair
US20030093147A1 (en) * 2001-11-13 2003-05-15 Ogle Matthew F. Medical devices that stimulate growth factor production
US7053046B2 (en) * 2001-12-21 2006-05-30 Mcgrath Kevin Peptide activators of VEGF
GB0206711D0 (en) * 2002-03-21 2002-05-01 Isis Innovation HIF Inhibitor
US20040197375A1 (en) * 2003-04-02 2004-10-07 Alireza Rezania Composite scaffolds seeded with mammalian cells

Also Published As

Publication number Publication date
ES2686777T3 (es) 2018-10-19
EP1676591B1 (en) 2018-08-01
EP1676591A2 (en) 2006-07-05
EP1676591A3 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
HK1199266A1 (en) Specific binding agents to hepatocyte growth factor
GB2456592B (en) Techniques to improve time seek operations
EP1952150A4 (en) METHODS AND COMPOSITIONS RELATED TO B-LYMPHOCYTE ANALYZES
GB2415577B (en) Improvements relating to telecommunications
HK1113689A1 (en) Novel cellular compositions and methods for their preparation
EP2012806A4 (en) METHODS AND COMPOSITIONS FOR MODIFYING CELLULAR FUNCTION
EP1791855A4 (en) METHODS AND COMPOSITIONS ASSOCIATED WITH ARGONAUTE PROTEINS
ZA200701558B (en) Improvements in or relating to organic compositions
EP1899910A4 (en) USING MESSAGES TO ENHANCE CRM FUNCTIONALITY
EP1920064A4 (en) COMPOSITIONS AND METHODS FOR INCREASING AMPLIFICATION EFFICIENCY
EP1755685A4 (en) METHOD FOR AUTOLOGIC STRAIN CELL TREATMENT
GB0503028D0 (en) Improvements relating to mobile telecommunications
ZA200803748B (en) Nematicidal compositions and methods
ZA200805080B (en) Methods and compositions for expanding T regulatory cells
EP1781337A4 (en) METHODS AND COMPOSITIONS FOR CELL ACTIVATION
PL1676591T3 (pl) Kompozycje i sposoby tworzenia unaczynionego środowiska dla przeszczepu komórkowego
EP1937799A4 (en) COMPOSITIONS AND METHODS FOR CULTIVATION OF EMBRYOS AND OOCYTES
GB0410324D0 (en) Improvements relating to engines
GB0425187D0 (en) Improvements to seals
ZA200702966B (en) Cryopreservation of cells
GB0427308D0 (en) Improvements relating to surfactant compositions
GB0419485D0 (en) Improvements to valve
GB2410770B (en) An improvement to two-phase flow-turbines
GB0613100D0 (en) Compositions and methods relating to cellular targeting
GB0403332D0 (en) Improvements in or relating to organic compositions